DeepCyto
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DeepCyto - overview
Established
2018
Location
Tianjin, -, China
Primary Industry
Healthcare IT
About
Established in 2018 and based in Tianjin, China, DeepCyto operates as a technology company dedicated to providing medical diagnoses and healthcare data analysis solutions via artificial intelligence and deep learning technology. It has sub-branch offices in Changsha, Shenzhen, and Portland, USA. The cooperative hospitals are Peking University Hospital, Fudan University Cancer Hospital, and other hospitals. In June 2019, DeepCyto closed venture funding from new investor Northern Light Venture Capital.
The company mainly provides DCS-1600, DSS-8200, Deepflo® flow cytometry Al cloud diagnostic platform, and DK-1200. The DCS-1600 is a cell medical image analyzer, which can be used for peripheral blood and bone marrow. The DSS-8200 is a slide-scanning imaging system, which can scan tissue samples, bone marrow smears, blood smears, microorganisms, and karyotypes. The DK-1200 is an automatic chromosome microscopy image scanning system, which can scan and analyze microscopic images of chromosome specimen slides.
The products and platforms mainly serve medical institutions, medical equipment, and testing reagent manufacturers.
Current Investors
SB China Venture Capital, YuanBio Venture, NLVC
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Website
www.deepcyto.cn
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.